• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Diamond Market
    Diamond News
    Diamond Stocks
    • Diamond Market
    • Diamond News
    • Diamond Stocks

    Petra Diamonds Announces its Trading Update for Year Ending June 30, 2016

    Jocelyn Aspa
    Jul. 25, 2016 09:19AM PST
    Diamond Investing

    Petra Diamonds (LSE:PDL) has announced its trading update for the year ending June 30, 2016 together with an updated analyst guidance through to June 30, 2017. As quoted in the press release: FY 2016 HIGHLIGHTS ·     FY 2016 production up 16% to 3.7 Mcts (FY 2015: 3.2 Mcts), above Company guidance of 3.6 – 3.65 …

    Petra Diamonds (LSE:PDL) has announced its trading update for the year ending June 30, 2016 together with an updated analyst guidance through to June 30, 2017.
    As quoted in the press release:

    FY 2016 HIGHLIGHTS

    ·     FY 2016 production up 16% to 3.7 Mcts (FY 2015: 3.2 Mcts), above Company guidance of 3.6 – 3.65 Mcts.

    ·     FY 2016 revenue up 1% to US$430.9 million (FY 2015: US$425.0 million), mainly due to an increase in volumes sold, most notably tailings carats sold from the newly established Kimberley Ekapa Mining (“KEM”) operation, partially offset by softer diamond prices in FY 2016.

    ·     Rough diamond prices on a like for like basis down ca. 6% for the Year, compared to FY 2015. The market showed signs of recovery and stabilisation during H2 FY 2016.

    ·     Total FY 2016 operating costs for SA operations increased in ZAR terms mainly due to inclusion of KEM from 18 January 2016. Absolute costs remained in-line with expectations despite ongoing inflationary pressures. The weakening in the Rand for the Year had a positive impact on the Dollar reported operating costs; further detail will be given in the Prelim Results announcement.

    ·     FY 2016 Operational Capex (excluding capitalised borrowing costs) of US$294.2 million (FY 2015: US$252.0 million).

    ·     Cash at bank at Year end of US$46.1 million (30 June 2015: US$166.2 million); this figure excludes debtors from the June diamond tenders received shortly after Year end of US$60.2 million (30 June 2015: US$57.6 million).

    ·     Net debt at 30 June 2016 of US$387.4 million (30 June 2015: US$172.1 million); Petra expects to be within the required covenant ratios for the measurement period as at 30 June 2016.

    Click here to read the full press release.

    The Conversation (0)

    Go Deeper

    AI Powered
    Top Gem and Diamond Stocks

    Top Gem and Diamond Stocks

    Close up of a rough diamond in a diamond mine.

    ASX-Listed Diamond Stocks

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES